Cambridge Investment Research Advisors’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-15,705	Closed	-$41K	–	3461
2024 Q3	$41K	Sell	15,705 -8,463	-35%	-$23.4K	﹤0.01%	3343
2024 Q2	$72K	Sell	24,168 -6,637	-22%	-$25.1K	﹤0.01%	3190
2024 Q1	$140K	Sell	30,805 -821	-3%	-$4.19K	﹤0.01%	3101
2023 Q4	$181K	Sell	31,626 -2,709	-8%	-$12.6K	﹤0.01%	2933
2023 Q3	$158K	Sell	34,335 -408	-1%	-$2.48K	﹤0.01%	2882
2023 Q2	$224K	Sell	34,743 -1,675	-5%	-$11.4K	﹤0.01%	2782
2023 Q1	$275K	Sell	36,418 -6,800	-16%	-$61.7K	﹤0.01%	2561
2022 Q4	$438K	Sell	43,218 -1,954	-4%	-$22.6K	﹤0.01%	2118
2022 Q3	$447K	Buy	45,172 +1,565	+4%	+$17.2K	﹤0.01%	2028
2022 Q2	$464K	Sell	43,607 -3,361	-7%	-$28.5K	﹤0.01%	2013
2022 Q1	$458K	Buy	46,968 +1,205	+3%	+$11.4K	﹤0.01%	2182
2021 Q4	$654K	Buy	45,763 +3,355	+8%	+$50.9K	﹤0.01%	1891
2021 Q3	$850K	Buy	42,408 +15,526	+58%	+$274K	﹤0.01%	1655
2021 Q2	$591K	Buy	+26,882	New	+$741K	﹤0.01%	1923